The use of lysergic acid diethylamide (LSD) tripled among young adults with past-year depression, results from the annual National Survey on Drug Use and Health (NSDUH) show. The increase was ...

Among psychedelic enthusiasts, April 19 or Bicycle Day honors a mind-altering ride taken by the Swiss chemist who created LSD. Bicycle Day marks a hallucinogenic ride that's considered the birth of ...

LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

Lysergic acid diethylamide-25 was synthesized in a Swiss laboratory in 1938. Early researchers called it “psychotomimetic” because it caused psychosis akin to schizophrenia. In the 1950s, the British ...

In a recent study published in the journal Translational Psychiatry, researchers from New Zealand conducted a phase I trial to assess the effect of micro-dosing of lysergic acid diethylamide (LSD) on ...

A cortical neuron treated with JRT, a synthetic molecule similar to the psychedelic drug LSD. Drugs like JRT might enable new treatments for conditions such as schizophrenia, without the ...

What do monkeys, LSD and Stanford University all have in common? More than you think, probably. The connection is one man: the famed novelist Ken Kesey. A colorful figure whose work infused American ...

A landmark clinical trial testing the effect of microdosing LSD on symptoms of attention-deficit hyperactive disorder (ADHD) recently delivered its first data readout and the results have been ...

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential. University of ...

WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...